← Evidence map

ReviewBlood neoplasia2026

Mutant calreticulin-directed immunotherapies in myeloproliferative neoplasms.

William L Heaton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41798678